ScholarLens Back to search
2022•European Journal of CancerOpen access

The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe

Renée Schmitz, Carine M. T. Sondermeijer, Vincent van der Noort, E. Engelhardt, Miranda Gerritsma, E. Verschuur, M. van Oirsouw, E. Bleiker, N. Bijker, R. Mann, Frederieke H van Duijnhoven, J. Wesseling

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Preference, Test (biology), Ductal carcinoma, Medicine, In situ, Internal medicine, Oncology, Cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe — Research Paper | ScholarLens